Osiris Therapeutics Inc., of Columbia, Md., presented 12 abstracts demonstrating the benefits of its viable human amniotic membrane, Grafix, at the Symposium on Advanced Wound Care in Las Vegas. One of the posters highlighted an academic lab study showing for the first time that product inhibits the growth of bacteria species associated with chronic wounds.